Chondrosarcoma CS Foundation Board of Directors

Dexter Jin, Ph.D.; is the senior scientist on the Cancer Genomics Research team at Foundation Medicine in Cambridge, MA. He did his doctoral work at the Massachusetts Institute of Technology, where I previously focused on understanding the invasive transition of breast cancers. At Foundation Medicine Dr Jin is on the Cancer Genomics Research team, where he uses FMI’s database of over 400,000 patient profiles for biomarker development and to better understand the genomics of rare cancers. Dr. Jin was invited to join the Chondrosarcoma Foundation because of his expertise in genetic sequencing.

William Cross, Ph.D. is currently a Research Fellow in the Department of Research Pathology, UCL Cancer Institute in London. He and Adrienne Flanagan, Ph.D. worked on the Genomics England 100,000 Genomes Project and looked at genetic sequencing of Chondrosarcoma Patients. Dr. Cross research involves genetic mutations found in chondrosarcoma cells that may have direct implications for patient outcome; namely that people with a specific mutation combination (in the genes IDH1 and TERT) do worse, hence they should perhaps be given more attention upfront. He examines the need for testing the presence of these biomarkers following diagnosis, which is done for other cancer types and is easy and cost effective in the modern oncology clinic.